Independent Wealth Network Inc. Has $235,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Independent Wealth Network Inc. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 464 shares of the healthcare conglomerate’s stock after acquiring an additional 101 shares during the quarter. Independent Wealth Network Inc.’s holdings in UnitedHealth Group were worth $235,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of UNH. Wesbanco Bank Inc. boosted its position in UnitedHealth Group by 4.8% in the 4th quarter. Wesbanco Bank Inc. now owns 51,868 shares of the healthcare conglomerate’s stock valued at $26,238,000 after buying an additional 2,365 shares during the last quarter. Sharp Financial Services LLC increased its position in UnitedHealth Group by 11.0% in the fourth quarter. Sharp Financial Services LLC now owns 885 shares of the healthcare conglomerate’s stock worth $447,000 after purchasing an additional 88 shares during the period. Phillips Wealth Planners LLC raised its holdings in UnitedHealth Group by 4.4% during the 4th quarter. Phillips Wealth Planners LLC now owns 2,767 shares of the healthcare conglomerate’s stock worth $1,441,000 after purchasing an additional 117 shares during the last quarter. Kelleher Financial Advisors grew its position in shares of UnitedHealth Group by 1.3% during the 4th quarter. Kelleher Financial Advisors now owns 3,315 shares of the healthcare conglomerate’s stock worth $1,677,000 after buying an additional 43 shares during the period. Finally, Marino Stram & Associates LLC lifted its holdings in UnitedHealth Group by 4.4% in the fourth quarter. Marino Stram & Associates LLC now owns 758 shares of the healthcare conglomerate’s stock valued at $383,000 after buying an additional 32 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

UNH has been the subject of a number of analyst reports. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. TD Cowen raised their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Trading Up 1.8 %

Shares of UnitedHealth Group stock opened at $528.94 on Friday. The stock has a market cap of $486.77 billion, a P/E ratio of 34.12, a P/E/G ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business’s 50 day moving average is $543.52 and its 200-day moving average is $563.78. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business earned $5.83 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.59%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.